Charcot arthropathy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

EPIDEMIOLOGY In 1968, Jean-Martin Charcot described neuroarthropathy in the foot in relation to tabes dorsalis (1). He proposed the first theory in how this process may occur. In 1936, Jordan was the first to described Charcot in diabetes (2). Charcot neuroarthropathy is a disabling and devastating condition. Although the cause of this potentially debilitating condition is not known, it is generally accepted that the components of diabetic neuropathy that lead to foot complications must exist. Untreated Charcot arthropathy may lead to a rocker bottom foot, which will lead to increased plantar pressure in the neuropathic foot. This cascade will lead to an ulceration and possible amputation. A recent study shows, however, that Charcot arthropathy alone may not pose a risk for amputation, but Charcot arthropathy along with an ulceration has 12 times increased risk of having an amputation (3).

Original languageEnglish (US)
Title of host publicationHigh Risk Diabetic Foot
Subtitle of host publicationTreatment and Prevention
PublisherCRC Press
Pages173-191
Number of pages19
ISBN (Electronic)9781420083026
ISBN (Print)9781420083019
DOIs
StatePublished - Jan 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Charcot arthropathy'. Together they form a unique fingerprint.

  • Cite this

    La Fontaine, J. (2010). Charcot arthropathy. In High Risk Diabetic Foot: Treatment and Prevention (pp. 173-191). CRC Press. https://doi.org/10.3109/9781420083026